ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The way that miR-377 inhibits cells that cause prostate cancer.

2.

Cancer detection recovered following pandemic disruptions

3.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

4.

Three out of ten breast cancers detected between screenings, study finds

5.

Screening for prostate cancer: is it time to give up digital rectal examination?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot